Results 61 to 70 of about 302,595 (156)
ABSTRACT Introduction Mpox disproportionately affects people with HIV (PWH), yet little is known about mpox vaccine awareness and uptake in low‐ and middle‐income countries. We evaluated mpox‐related knowledge, attitudes and practices (KAP) among PWH in the Dominican Republic to identify determinants of vaccine awareness and uptake.
Robert Paulino‐Ramirez +5 more
wiley +1 more source
The Mpox vaccine (JYNNEOS vaccine) [PDF]
Mpox (formerly known as monkeypox) is caused by a virus that is related to the virus that causes smallpox. JYNNEOS is a 2-dose vaccine that was developed to protect against both mpox and smallpox. People need to get both doses of the vaccine for the best
core +2 more sources
Background Following the 2022 outbreak, vaccination against mpox became available in many European countries using a third-generation non-replicating smallpox vaccine (MVA-BN).
Maria Gabriella Donà +7 more
doaj +1 more source
Mpox Awareness, Risk Reduction, and Vaccine Acceptance among People with HIV in Washington, DC
People with HIV (PWH) are disproportionally affected by mpox and at risk of severe complications. We assessed mpox knowledge, adoption of preventive behaviors, and vaccination attitudes among PWH enrolled in a longitudinal HIV cohort in Washington, DC ...
Elisabeth W. Andersen +6 more
doaj +1 more source
Mpox (Monkeypox) and the Eye: Ocular Manifestation, Diagnosis, Treatment and Vaccination
At present, the world is at the tipping point of the outbreak of mpox. The World Health Organization has declared the current mpox outbreak a ‘public health emergency of international concern’.
Kyoko Ohno-Matsui +9 more
core +1 more source
Background The 2022 mpox outbreak in the United States primarily affected sexual minority men. Barrier to healthcare access, treatment, and vaccination against mpox are not well characterized. Stigma surrounding mpox has not been well quantified, and may
Angelique E. Boutzoukas +7 more
doaj +1 more source
Appraising the current landscape of reviews on mpox vaccination: a rapid evidence map
Introduction Vaccination is a potent countermeasure for interrupting the spread of mpox, which is currently a priority public health problem in Africa. Backed by emergency declarations from both the World Health Organization (WHO) and the Africa Centres ...
Abdu A. Adamu +8 more
doaj +1 more source
Optimizing Microneutralization and IFN-γ ELISPOT Assays to Evaluate Mpox Immunity
Background: Available assays to measure pox virus neutralizing antibody titers are laborious and take up to 5 days. In addition, assays to measure T cell responses require the use of specific antigens, which may not be the same for all pox viruses.
Yinyi Yu +7 more
doaj +1 more source
BackgroundMpox (monkeypox) remains a global public health threat. However, data on mpox-related knowledge, attitudes, and practices (KAP) and vaccination willingness among Chinese medical students, who are key future health care practitioners, remain ...
Yang Liu +6 more
doaj +1 more source
In May 2022, the world witnessed the emergence of human monkeypox (MPOX), a new zoonotic viral disease in multiple non-endemic countries. This health threat has been associated with increased anxiety, especially after the COVID-19 catastrophe.
Mohamed Lounis +3 more
core +1 more source

